View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. Analysis
August 16, 2021updated 17 Aug 2021 10:02am

Video: how smart, integrated tech platforms can streamline complex cancer studies

Axiom executives discuss how integrated platforms can help address the operational challenges of clinical trials in oncology.

By Chris Lo

As clinical trials in oncology try to incorporate technology more efficiently in their day-to-day operations, its uniform implementation across study sites continues to be a challenge. Clinical sites use disparate methods of record-keeping and allowing those to use one cohesive method is critical but demanding.

In a recent discussion on this topic, Axiom Real-Time Metrics’ director of project management Quinn Zarubick emphasised the need to collaborate early with key opinion leaders at clinical sites to understand the feasibility of implementing a unified platform. In a discussion at Arena International’s Clinical Operations in Oncology Trials 2021 virtual conference held in June, Zarubick said this would allow the study to take a per-site approach, but at the same time make it as streamlined as possible.

The main advantage with using a unified platform is to avoid the need for reconciliation at the end of the study, said Axiom’s associate director for RTSM/IWRS Heather DiFruscia. If everything is completed in real-time, that sets the study up for success and the sites for a clean close-out, she added.

To watch the full presentation and see more clinical trials events please click here.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU